Mankind Pharma Ltd is a 34-year-old pharma company led by Mr Ramesh Juneja (Chairman & Whole-Time Director), Mr Rajeev Juneja (Vice Chairman & MD), and Mr Sheetal Arora (CEO & Whole-Time Director), and they have a more than 21,000-strong workforce. They are present in 25 countries. Their products are Pharmaceuticals, Generic drugs, OTC, FMCG, Diagnostics, etc. Mankind has shown nearly 100% growth in its share price in the last 5 years. However, their revenue is 12,207 crore, and their net profit is 2,007 crore for FY 2024-25.

Establishment:

1991 in New Delhi, India

Website:

Company Listed On:

Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)

Core Business:

Mankind Pharma Ltd provides pharmaceutical products, medicines, and healthcare products.

Financial Performance:

Mankind Pharma Ltd has shown a strong financial performance in last two years. The company raised revenue of around 12000 crore and they have continued strong profitability.

Future Outlook:

• Launching of new pharmaceutical products and distributing them in the global markets.
• Improving healthcare products and medicines while focusing on affordability and quality.
• Focus on research and development.
• Adopting new technologies and innovation.

Disclaimer:

Unsold 70 publishes research-based articles, blogs, news, and company profiles to help readers understand businesses along with their future prospects. It will help you learn about the stock market and mutual funds. We research the companies as per our algorithm and find companies that need further research. However, the Mankind Pharma Ltd company profile is not an investment recommendation, as past performance does not guarantee future results. You should perform your own research and seek advice from a SEBI-registered financial advisor before making investment decisions. Visit our weekly research page to know about the research work done by our research team. It will help you to take up the companies for further research.